ABEV vs PRMB: stock comparison and AI forecast
Ambev S.A. (ABEV) and Primo Brands Corp (PRMB) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABEV Ambev S.A.
- Price
- $2.79 -14.9% · 6M
- Market Cap
- $43.97B
- P/E Ratio
- 4.2x
- Size
- large-cap
- AI Forecast
PRMB Primo Brands Corp
- Price
- $22.15 -0.4% · 6M
- Market Cap
- $8.03B
- P/E Ratio
- 48.2x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ABEV is 5.5 times larger than PRMB by market capitalization ($43.97B against $8.03B).
- ABEV trades at 4.2 times trailing earnings, PRMB at 48.1 times.
- Over the last six months PRMB returned -0.4% and ABEV -14.9%.
- ABEV turns 17.5% of its revenue into net income, against 3.1% for PRMB.
- PRMB carries 2.55 times debt per unit of equity, against 0.64 times for ABEV.
- PRMB yields 2.11% in dividends; ABEV pays none.
- Both companies share the SEC industry classification Beverages.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABEV | PRMB |
|---|---|---|
| Market Cap | $43.97B | $8.03B |
| P/E Ratio | 4.17x | 48.15x |
| P/B Ratio | – | 2.63x |
| Dividend Yield | – | 2.11% |
| EPS | $0.67 | $0.46 |
| Book Value/Share | – | $8.41 |
| Revenue/Share | $3.84 | $18.76 |
| FCF/Share | $0.84 | $0.76 |
Profitability & Margins
| Metric | ABEV | PRMB |
|---|---|---|
| ROE | 67.0% | 6.8% |
| ROA | 40.6% | 1.9% |
| ROIC | 82.1% | 6.2% |
| Gross Margin | 50.7% | 29.4% |
| Operating Margin | 24.2% | 8.6% |
| Net Margin | 17.5% | 3.1% |
| EBT Margin | 20.2% | 4.2% |
| Tax Rate | 2.5% | 31.9% |
Financial Health
| Metric | ABEV | PRMB |
|---|---|---|
| Current Ratio | 0.96x | 1.11x |
| Quick Ratio | 0.73x | 0.92x |
| D/E Ratio | 0.64x | 2.55x |
| Financial Leverage | 1.65x | 3.55x |
| Interest Coverage | – | 4.8x |
| Working Capital | -$315M | $149M |
Cash Flow
| Metric | ABEV | PRMB |
|---|---|---|
| Operating Cash Flow | $17.20B | $691M |
| Free Cash Flow | $13.28B | $277M |
| Capital Spending | -$3.92B | -$414M |
| OCF Growth YoY | 22.9% | -8.7% |
| FCF Growth YoY | 0.0% | -26.3% |
| FCF/Sales | 22.0% | 4.1% |
| CapEx/Sales | 6.5% | 6.1% |
Operational Efficiency
| Metric | ABEV | PRMB |
|---|---|---|
| Asset Turnover | 2.32x | 0.63x |
| Receivables Turnover | 53.1x | 12.1x |
| Inventory Turnover | 15.8x | 18.1x |
| Fixed Assets Turnover | 12.2x | 3.2x |
| Days Sales Outstanding | 7 days | 30 days |
| Days Inventory | 23 days | 20 days |
| Payables Period | 52 days | 41 days |
| Cash Conversion Cycle | -22 days | 9 days |
Income Statement
| Metric | ABEV | PRMB |
|---|---|---|
| Total Revenue | $60.48B | $6.80B |
| Operating Income | $14.64B | $585M |
| Net Income | $10.57B | $208M |
| SG&A Expense | – | $1.34B |
| Cost of Goods Sold | $29.81B | $4.80B |
Dividend & Shareholder Information
| Metric | ABEV | PRMB |
|---|---|---|
| Dividends Per Share | – | $0.47 |
| Payout Ratio | – | 102.2% |
| Shares Outstanding | 15762M | 362M |
| Net Income Growth | 25.7% | 266.8% |
| EPS Growth | 26.2% | – |
ABEV vs PRMB: stock comparison and AI forecast
Which is bigger, ABEV or PRMB?
ABEV is 5.5 times larger than PRMB by market capitalization ($43.97B against $8.03B).
Which is cheaper on earnings, ABEV or PRMB?
ABEV trades at 4.2 times trailing earnings, PRMB at 48.1 times.
Which stock performed better over the last six months, ABEV or PRMB?
Over the last six months PRMB returned -0.4% and ABEV -14.9%.
Which one does Intratio's AI model rank higher, ABEV or PRMB?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.